{"id":"https://openalex.org/W2942850877","doi":null,"title":"Targeting AXL Protein Could Overcome Resistance to Erlotinib in NSCLC","display_name":"Targeting AXL Protein Could Overcome Resistance to Erlotinib in NSCLC","publication_year":2012,"publication_date":"2012-07-11","ids":{"openalex":"https://openalex.org/W2942850877","mag":"2942850877"},"language":"en","primary_location":{"id":"mag:2942850877","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/lung-cancer/targeting-axl-protein-could-overcome-resistance-erlotinib-nsclc","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012027631","display_name":"Dave Levitan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Dave Levitan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5012027631"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.49438431,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/axl-kinase","display_name":"AXL kinase","score":0.8690000176429749},{"id":"https://openalex.org/keywords/erlotinib-resistance","display_name":"erlotinib resistance","score":0.921999990940094},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9210000038146973},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.9319999814033508},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5920000076293945},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5040000081062317}],"concepts":[{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.8496859073638916},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39473697543144226},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3427225351333618},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.32279694080352783},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25425049662590027},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.24721810221672058},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.10099580883979797}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2942850877","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/lung-cancer/targeting-axl-protein-could-overcome-resistance-erlotinib-nsclc","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1983774108","https://openalex.org/W7096917794","https://openalex.org/W4250365963","https://openalex.org/W3191611512","https://openalex.org/W2981975783","https://openalex.org/W2885455850","https://openalex.org/W2165359485","https://openalex.org/W7169753241","https://openalex.org/W2763670880","https://openalex.org/W2525470496"],"abstract_inverted_index":{"New":[0],"research":[1],"now":[2],"suggests":[3],"that":[4],"targeting":[5],"AXL":[6],"kinase":[7,15],"could":[8],"reduce":[9],"the":[10],"resistance":[11],"to":[12,21],"EGFR-targeted":[13,22],"tyrosine":[14],"inhibition,":[16],"and":[17],"allow":[18],"further":[19],"response":[20],"therapies":[23],"in":[24],"lung":[25],"cancer.":[26]},"counts_by_year":[],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2019-05-09T00:00:00"}